+ All Categories
Home > Documents > Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Date post: 02-Jan-2016
Category:
Upload: shonda-sutton
View: 216 times
Download: 2 times
Share this document with a friend
Popular Tags:
28
Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD
Transcript
Page 1: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Prevention of BSI and VAPMeasuring Change in Outcomes

Part ITed Speroff, PhD

Page 2: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

NNIS Surveillance Data

• Central line-associated BSI rate– 5.0/1000 central line-days

• Ventilator-associated pneumonia rate– 5.8/1000 ventilator-days

• The numerator is the number of events– Number of patients with infection or pneumonia

• The denominator is the number of central-line or ventilator days, standardized to 1,000– Census data in the ICU, all patients with lines or on ventilator

• NNIS rate is calculated as number of BSI or VAP events (numerator) divided by observed number of line or vent days for the ICU (denominator) times 1,000

Page 3: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Characteristics ofNNIS Rate Data

• Requires aggregating data over a large sample

• Takes time to accumulate data• Appropriate for Surveillance or Quality

assurance• Appropriate for detecting a rate increase• Not appropriate for detecting a rate

decrease unless sample is huge• Insufficient for Quality Improvement

Page 4: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Statistical Process Control Charts• Used in QI to detect improvement (did it

work?)

• Chart:

Central Line is Mean

UCL

LCL

Upper (UCL) and lower (LCL) control limits are usually 3 sigma units from the mean. A data point above the UCL or below the LCL is a significant change. There are additional control chart rules for detecting change.

X-axis is Time Scale: days, weeks months

Page 5: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

BSI Rates and Control Chart

• Excel Tool

• Naming and Saving the File

• Entering Baseline Data

• Setting the Baseline Period for the Control Chart

• Editing Chart and Printing

Page 6: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.
Page 7: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Name and Save the FileSave Often

Page 8: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Rename the Template File

Page 9: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

HCAHospitalName_ICUName_ICUSafety_MonYr

Page 10: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Spreadsheet is now calledMusic City_MICU_ICUSafety_Sep06

Page 11: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Note the Tabs at the Bottom:4 WorksheetsBSI NNIS RateVAP NNIS Rate

Page 12: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

BSI NNIS Rate

Page 13: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

First Entry: Month/Year10/2004

Page 14: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

First Entry: CVC Days

Page 15: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Collecting CVC Days

Page 16: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

First Entry: CVC-BSI Infections

Page 17: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Continue Data Entry

Page 18: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Data for Baseline Period Have Been EnteredNote: Data + Chart

Page 19: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Set Baseline Period:Move Cursor to Cell F20

Page 20: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Baseline goes from row 20 to 34Edit $D$50 to $D$34

Page 21: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Move Cursor to Cell G3Edit the Text

Page 22: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Text is a Reminder to You of the Baseline Period:

the data for mean and control limits

Page 23: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Chart: To Edit TitleMove Cursor on Title and Click

Page 24: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Edit to your Hospital Nameand ICU Name

Page 25: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Continue Data Entry:Only Baseline Data determine

Mean and Control Limits

Page 26: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

Data Complete through 6/2006What do you see?

Page 27: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.
Page 28: Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

End of Part I

Questions and Commentsso far?

Continue to Part II


Recommended